The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Oncology Reviews
(Sep 2023)
Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
John Nemunaitis,
Laura Stanbery,
Adam Walter,
Adam Walter,
Rodney Rocconi,
Philip Stephens,
Philip Stephens
Affiliations
John Nemunaitis
Gradalis, Inc, Dallas, TX, United States
Laura Stanbery
Gradalis, Inc, Dallas, TX, United States
Adam Walter
Gradalis, Inc, Dallas, TX, United States
Adam Walter
ProMedica, Toledo, OH, United States
Rodney Rocconi
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Mobile, AL, United States
Philip Stephens
Gradalis, Inc, Dallas, TX, United States
Philip Stephens
Naveris, Waltham, MA, United States
DOI
https://doi.org/10.3389/or.2023.11471
Journal volume & issue
Vol. 17
Abstract
Read online
No abstracts available.
Keywords
homologous recombination
neoantigen
immune response
ovarian cancer
immunotherapy
WeChat QR code
Close